Corporate Corruption Media Articles

Excerpts of Key Corporate Corruption Media Articles in Major Media

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Next month, Dr. Iris Pear will present her groundbreaking new study at the International Conference on Atomic and Nuclear Physics. Or at least she would, if she were a real person. Iris Pear ... is the invention of Christophe Bartneck, an associate professor ... at New Zealand's University of Canterbury. The study in question is completely nonsensical, procedurally generated by iOS’s autocomplete function. Why, then, did a conference for “leading academic scientists” select it for presentation? Dr. Bartneck received an invitation to submit research for an upcoming conference on nuclear physics. With virtually no background in the subject, he decided to use autocomplete to help write his facetious submission. “I started a sentence with ‘atomic’ or ‘nuclear’ and then randomly hit the autocomplete suggestions,” Bartneck wrote. “The text really does not make any sense.” Bartneck’s abstract is both off-topic and unreadable. And yet, Bartneck received a follow-up email just three hours later – his abstract had been accepted. From there, he could pay $1,099 to register as an academic speaker at the Atlanta, Ga. convention. Many journals are slacking on peer review. In a kind of meta-study, Harvard biologist and science journalist John Bohannon submitted false studies to 304 open-access journals. More than half accepted his paper, which featured fake names and several basic chemistry errors. But the acceptance of Bartneck’s fake study may be less surprising. The conference smacks of a scam.

Note: For more along these lines, see concise summaries of deeply revealing science corruption news articles from reliable major media sources.

Mexican immigrants who speak little English. Older adults with memory problems. College students opening their first bank accounts. Small-business owners with several lines of credit. These were some of the customers whom bankers at Wells Fargo, trying to meet steep sales goals and avoid being fired, targeted for unauthorized or unnecessary accounts, according to legal filings and statements from former bank employees. “The analogy I use was that it was like lions hunting zebras,” said Kevin Pham, a former Wells Fargo employee in San Jose, Calif., who saw it happening at the branch where he worked. “They would look for the weakest, the ones that would put up the least resistance.” Wells Fargo would like to close the chapter on the sham account scandal. But lawmakers and regulators say they will not let it go that quickly, and emerging evidence that some victims were among the bank’s most vulnerable customers has given them fresh ammunition. This week, three members of the Board of Supervisors in San Francisco, Wells Fargo’s hometown, introduced a resolution calling on the city to cut all financial ties with the bank. They cited both the recent scandal and past cases — particularly the $175 million that Wells Fargo paid in 2012 to settle accusations that its mortgage brokers had discriminated against black and Hispanic borrowers. Current and former Wells Fargo employees say the problems continued well into this year.

Note: For more along these lines, see concise summaries of deeply revealing banking corruption news articles.

Concerns about the inner workings of the U.S. Centers for Disease Control and Prevention (CDC) have been mounting in recent months amid disclosures of cozy corporate alliances. Now a group of more than a dozen senior scientists have reportedly lodged an ethics complaint alleging the federal agency is being influenced by corporate and political interests in ways that short-change taxpayers. A group calling itself CDC Scientists Preserving Integrity, Diligence and Ethics in Research, or CDC SPIDER, put a list of complaints in writing in a letter to the CDC Chief of Staff and provided a copy of the letter to [a] public watchdog organization. The members of the group have elected to file the complaint anonymously for fear of retribution. “It appears that our mission is being influenced and shaped by outside parties and rogue interests... and Congressional intent for our agency is being circumvented by some of our leaders. What concerns us most, is that it is becoming the norm and not the rare exception,” the letter states. The complaint cites among other things a “cover up” of the poor performance of a women’s health program called ... WISEWOMAN. The complaint alleges there was a coordinated effort within the CDC to misrepresent data given to Congress. “Definitions were changed and data ‘cooked’ to make the results look better than they were,” the complaint states. And the complaint cites as “troubling” the ties between soft drink giant Coca-Cola Co. ... and two high-ranking CDC officials.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health.

The world cannot rely solely on free markets to deliver medicines needed by billions of people in poor countries, so governments should commit to a legally binding convention to coordinate and fund research and development. That's the conclusion of a major United Nations report. The high-level panel was set up last year by UN Secretary-General Ban Ki-moon to find solutions to the "policy incoherence" between the rights of inventors, international human rights law, trade rules and public health needs. The final report ... calls for a de-linkage of R&D costs and drug prices — at least in areas where the system is failing, such as tropical diseases and the hunt for new antibiotics against "superbug" resistant bacteria. The report attacks the "implicit threats" it says are sometimes used by Western governments and companies to stop poorer countries from exercising their right to over-ride drug patents under World Trade Organization rules. That may not go down well in Washington, given the United States' long-standing defence of the international intellectual property system, which has governed world trade for more than two decades. The panel also calls for greater transparency on the true cost of developing a new drug, citing estimates of anything between $150 million US and $4 billion US per medicine. And it wants disclosure on the real prices paid by insurers and governments for drugs, after discounts. The UN panel consisted of representatives from government, academia, health activism and industry.

Note: Big Pharma has long lobbied for protection of its rights to huge profits from new medicines and kept secret its costs for R&D by refusing to separate these costs from marketing costs. For lots more, read a profoundly revealing essay by the former head of one of the most prestigious medical journals in the world. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and income inequality.

As Hurricane Matthew churned toward Haiti at full force last week, France Francois knew she was powerless to stop the impending natural disaster. But with time running out, the 30-year-old Haitian American thought she might be able to help the island nation avoid the man-made disaster that she expected to follow. Before the storm struck, Francois, a former development worker in Haiti, turned to Facebook and composed a list explaining how people could help the hurricane-ravaged country. Her first instruction: "Don't give to the American Red Cross." Instead, she wrote, people should send money to "Haitian-led" organizations and "not your missionaries and useless college kids." Her post has been shared thousands of times — in part, she believes, because it tapped into a growing consensus among Haitians and Haitian Americans that the American Red Cross can no longer be trusted to effectively manage humanitarian efforts in the Caribbean nation. Those feelings have been bolstered by a widely circulated investigation by NPR and ProPublica, which found that the Red Cross grossly mismanaged its response to Haiti's 2010 earthquake. Speaking to reporters Friday, President Obama told Americans to help Haitians by going "to the American Red Cross," reiterating a standard relief message that exasperates many in the global Haitian community. But it appears that trust in the organization may be eroding.

Note: For lots more on corruption in the Red Cross, see this series of NPR articles. NPR shows that the Red Cross spent 1/4 of all donations to help Haiti on "internal expenses." For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

Bee colonies have been dying off in high numbers, with suspicion falling on agricultural pesticides like herbicides and fungicides, as main factors behind the declines. Now, a new study out of the University of Maryland is the first to look at how a “cocktail” of all of various pesticides could be impacting bee colonies over time. “Our results fly in the face of one of the basic tenets of toxicology: that the dose makes the poison,” study senior author Dennis van Engelsdorp, an assistant professor of entomology at the University of Maryland, said. “We found that the number of different compounds was highly predictive of colony death, which suggests that the addition of more compounds somehow overwhelms the bees’ ability to detoxify themselves.” The study looked at 91 honey bee colonies that were owned by three migratory commercial beekeepers over one farming season. The research team examined 93 pesticide compounds that were found in the colonies throughout the season. These compounds were found building up in the bees’ wax in processed pollen, [as well as] in the bodies of nurse bees. The researchers ... measured three key things: the total number of pesticides, the total number of pesticides that were above a minimum level of toxicity, and each colony’s “hazard quotient,” which factors in the hazard posed by the total toxicity of all pesticides present in the colony. What did the researchers find? Unfortunately, all three measures corresponded with a higher probability of colony death or the loss of the queen bee.

Note: This study was published in Nature Scientific Reports, and found that some compounds regarded as "bee-safe" could be a major contributors to honey bee colony losses. Prior to this, neonicotinoid pesticides were found to be connected to colony collapse disorder. Bayer, a major manufacturer of this pesticide, attempted to cover up the connection between its products and the massive die off of bees.

Hillary Clinton took nearly every precaution to ensure voters would never know what she told investment bankers, lobbyists and corporate executives in dozens of closed-door paid speeches before running for president. Turns out, the Democratic presidential nominee had good reason to do so. She is ... happy to cut backroom deals with corporate interests and curry favor with Wall Street for campaign dollars. The WikiLeaks organization on Friday posted ... emails obtained in a hack of the Clinton campaign chairman’s personal email account. Among the documents posted online was an internal review of the speeches conducted by campaign aides to survey the political damage her remarks could cause if they ever became public. In what aides calculated were the most damaging passages, she reflects on the necessity of “unsavory” political dealing. To investment bankers from Goldman Sachs and BlackRock, Clinton admits that she’s “kind of far removed” from the middle-class upbringing that she frequently touts on the campaign trail. And in speeches to some of the country’s biggest banks, she highlighted her long ties to Wall Street ... saying that she views the financial industry as a partner in government regulation. In an effort to keep those speeches private, strongly worded contracts prohibited unauthorized recordings, reporters were banned and, in some cases, blog posts about her remarks pulled off websites.

Note: BBC has an article listing 11 intriguing revelations from the recent Wikileaks release. The emails also showed discussion of the Clinton campaign's interest in "elevating" Trump and other 'extreme' Republican candidates to make the party's eventual nominee 'unpalatable'. In 2013 alone, Clinton received $2.3 million for delivering these speeches. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the financial industry.

The scale of sexual harassment and gender violence by UK university staff has been likened to the scandals involving the Catholic church and Jimmy Savile in accounts shared by more than 100 women with the Guardian. Their stories – including those of verbal bullying, serial harassment, assault, sexual assault and rape – expose an alarming pattern of abuse and harassment in British universities which remains largely hidden. Many women said they had not pursued complaints for fear of jeopardising their academic careers. Those who did complain said they felt isolated and unprotected, while the more powerful men they accused appeared to be untouchable. The women’s accounts follow an exclusive Guardian report on the use of non-disclosure agreements in university sexual harassment cases. Jennifer Saul, professor of philosophy at the University of Sheffield and an expert on sexual harassment in higher education, said she was not surprised by the ... stories: “There’s a systemic problem. Too often, victims are afraid to come forward for fear of retaliation. “When they do come forward, often they are brushed off or not believed. When they are believed, their allegations are still often dismissed as unprovable. Even when things are taken more seriously, harassers are generally allowed to leave quietly, which enables them to move some place else and do the same thing.” Many of the women who made complaints ... felt they were the ones on trial.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and sexual abuse scandals.

Using the playbook of Mylan, Turing and, well, their own company, Valeant Pharmaceuticals has hiked the price of yet another life-saving treatment to astronomical values. This time, it’s calcium EDTA, a lead poisoning treatment that cost US hospitals and poison control centers about $500 for a packet of six ampules (6 grams) before 2012, when Valeant acquired the drug. Poison control experts now say that US centers pay about $5000 per gram for the drug, compared to $15 per gram for Canadians. In a 6-year period ... Valeant increased the US price of the drug by as much as 7200%. Two physicians - Michael Kosnett from the University of Colorado School of Medicine and Timur Durrani at the University of California, San Francisco (UCSF) - expressed their concerns about these price hikes in a letter to U.S. Rep. Elijah Cummings (D-Md), the ranking member of the House Committee on Oversight and Government Reform. According to Kosnett and Durrani, the average price per milliliter for the drug went from $18.57 in 2008 to $1346.37 in 2014. U.S. hospitals have no other source for calcium EDTA. Most of those who develop acute lead poisoning are children. The effects of lead poisoning are lasting and profound. Calcium EDTA is on the World Health Organization’s Model List of Essential Medicines, which lists medications that are most critical for a healthcare system to have on hand.

Note: For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

It's rare to get a glimpse behind the curtain of pharmaceutical marketing. CBC [has] learned about a stealth marketing campaign involving a drug company, a well-known Canadian comedian, a doctor and a public relations firm. "Cathy Jones of This Hour Has 22 Minutes is on a mission to get women to start talking about female sexual health after menopause - and particularly, their vaginas," wrote PR company GCI Group in a press release, offering to arrange an interview. But nowhere did it say this "mission" was initiated and sponsored by Novo Nordisk Canada Inc., which makes a vaginal hormone pill. Nor did GCI's release specify that Jones was paid to give media interviews about vaginal atrophy. When CBC asked if there was a drug company involved, the PR firm said yes, Novo Nordisk, but that was to be kept secret. "No parties including GCI want any mention of the drug or drug company," CBC was told. "It's an unbranded campaign." In other words, it's marketing that looks like any other lifestyle article in news. This is what it looks like on the Globe and Mail's website. There was originally no mention of Novo Nordisk sponsoring the campaign. Is it OK for a drug company, behind a curtain, to generate news about a condition and then encourage women to see their doctor? "No, it is not OK," says Dr. Jerilynn Prior [with] the University of British Columbia. "It is misrepresenting the marketing purpose behind it." This is a rare public example of something that happens all the time.

Note: For more along these lines, see concise summaries of deeply revealing news articles about Big Pharma corruption and the manipulation of public perception.

Super PACs seeking to influence the 2016 elections have collected more than $1 billion, a record haul driven by jumbo-sized contributions from rich donors on both sides of the aisle. Just 10 mega-donor individuals and couples contributed nearly 20 percent of the $1.1 billion raised by super PACs by the end of August. The total exceeds the $853 million that super PACs collected in the entire 2012 cycle. The top givers were split roughly equally along party lines, with five Republicans, four Democrats and one independent. Together, super PACs seeking to sway the White House and congressional races have pumped more than $674 million into TV ads and other outreach through September, filings show. By the end of the 2012 elections, such groups had spent $608 million. The figures illustrate how American campaigns have been reordered by the ability to give unlimited sums to political committees. In the six years since the Supreme Court’s Citizens United v. Federal Election Commission decision created new paths for massive contributions to flow into elections, a tiny sliver of donors with immense financial capacity have rushed to participate. Along with the $1.1 billion raised by super PACs, hundreds of millions more has been directed into politically active nonprofits on both sides of the aisle that can keep the names of their contributors secret. The huge sums washing through campaigns are contributing to a growing estrangement between voters and the political system.

Note: Read more about how ghost corporations are funding the 2016 elections. For more along these lines, see concise summaries of deeply revealing elections corruption news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Elections Information Center.

Yahoo has been accused of secretly building a customised software programme to search all of its customers’ incoming emails for specific information provided by US intelligence officials. The company complied with a classified US government directive, scanning hundreds of millions of Yahoo Mail accounts at the behest of the National Security Agency or FBI. Reuters said that a number of surveillance experts said this represented the first case to surface of a US Internet company agreeing to a spy agency’s demand by searching all arriving messages, as opposed to examining stored messages or scanning a small number of accounts in real time. The agency also said it was unable to determine what data the company had handed over, and if the intelligence officials had approached other email providers besides Yahoo. US phone and Internet companies are known to have handed over bulk customer data to intelligence agencies. But some former government officials and private surveillance experts said they had not previously seen either such a broad directive for real-time Web collection or one that required the creation of a new computer program. “I’ve never seen that, a wiretap in real time on a ‘selector’,” said Albert Gidari, a lawyer who represented phone and Internet companies on surveillance. A selector refers to a type of search term used to zero in on specific information. He added: “It would be really difficult for a provider to do that.”

Note: For more along these lines, see concise summaries of deeply revealing news articles about corporate corruption and the disappearance of privacy.

In his 93 years, Bob Wallace has seen some product-pricing doozies over the decades, but the nonstop national furor over the stratospheric price hikes for EpiPens - now retailing above $700 for a two-pack - was the final shot. Wallace and Roland Krevitt, a veteran Scotts Valley manufacturing and tooling consultant, set out to demystify the cost to produce the EpiPen, piece by piece. The auto-injector delivers a lifesaving dose of adrenaline to treat serious allergic reactions to everything from bee stings to food. [They crunched] the costs for molding and manufacturing the nozzle, needle, syringe, springs, safety cap - and 0.3 mg of epinephrine. Their startling estimate of the cost for a two-pack of EpiPens: $8.02. And that even included the bright-yellow box. The pharmaceutical giant Mylan is the latest drugmaker to withstand a public lashing over skyrocketing drug prices. While politicians and patients demand explanations ... policy experts and drug makers blame an American health care system built on an ever-expanding pool of middlemen whose piece of the action is driving up the final bill. [Mylan’s] chief executive, Heather Bresch, recently told a congressional committee her company pays $69 per two-pack to the firm that actually manufactures the EpiPen, [and] pointed to charts explaining why the company charges a $608 wholesale price for a two-pack. The Wall Street Journal ... reported last week that Mylan low-balled its calculation of EpiPen profits to Congress.

Note: Read more about Mylan's price gouging on EpiPens. For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

You are undoubtedly familiar with so-called “sharing economy” titans such as Uber and Airbnb. Both companies are wreaking havoc on existing business models. But there is a problem. These are not truly “sharing economy” companies. For the record, I’m with Harvard Business Review authors Giana M. Eckhardt and Fleura Bardhi who made a strong case against using the term “sharing economy” when it comes to firms like Uber and Airbnb. The authors suggested these sorts of businesses - where products and services are traded on the basis of access rather than ownership, when trade is done temporarily and not permanently - ought to be referred to as the “access economy.” While there isn’t anything fundamentally wrong with companies like Uber or Airbnb ... they are not examples of organizations who are truly “sharing”. [Each company] extracts money from its “partners” and reinvests the profit in itself, not those who are its laborers. Which brings me to ... the business model of a “Platform Cooperative.” In its simplest form, a Platform Cooperative is defined as “worker–owned cooperatives designing their own apps-based platforms, fostering truly peer-to-peer ways of providing services and things”. Put differently, those doing the work are owners and are both compensated for such effort and regarded as members of the greater team. A Platform Cooperative is not in it to extract money from its labourers through the rental of talent, service or even capital. Its business model is not about renting access.

Note: Read a great article describing 11 "platform cooperatives" which create a real sharing economy.

More than a quarter of the Food and Drug Administration employees who approved cancer and hematology drugs from 2001 through 2010 left the agency and now work or consult for pharmaceutical companies, according to research published by a prominent medical journal. [Dr. Vinay] Prasad and his colleague Dr. Jeffrey Bien ... tracked 55 FDA reviewers in the hematology-oncology field from 2001 through 2010, using LinkedIn, PubMed and other publicly available job data. The researchers found that of the 26 reviewers who left the FDA during this period, 15 of them, or 57 percent, later worked or consulted for the biopharmaceutical industry. Put another way, about 27 percent of the total number of reviewers left their federal oversight posts to work for the industry they previously regulated. Prasad and Bien published their findings as a research letter in The BMJ, formerly The British Medical Journal. "If you know in the back of your mind that your career goal may be to someday work on the other side of the table, I wonder whether that changes the way you regulate," Prasad said. "There's a lot of room for interpretation in deciding whether or not a cancer drug should be approved," he said, because so many studies of cancer drugs rely on what's called a "surrogate endpoint." But ... there isn't always evidence that surrogate endpoints are linked to better health outcomes for patients, suggesting that some approved drugs aren't as beneficial as they appear.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.

Following widespread outrage and a blistering Senate Banking Committee hearing last week, Wells Fargo CEO John Stumpf has said he’ll forfeit his outstanding stock awards of about $41 million. Wells Fargo’s former retail-banking head, Carrie Tolstedt, has agreed to forfeit outstanding stock awards of about $19 million. The givebacks are being done in response to charges that the bank opened some 2 million fraudulent deposit and credit card accounts in its customers’ names. Wells Fargo had already agreed to pay $185 million to settle those charges with regulators, but, clearly, that wasn’t enough. The public is worn out by Wall Street’s bad behavior - and it’s also tired of watching low-level employees be scapegoated while top executives get off scot-free. Wells had fired more than 5,000 employees connected to the illegal sales practices, but done nothing to punish senior executives. No one is buying the story that a scandal this large was the work of rogue employees at the bottom of the totem pole. Part of the reason for the alleged unauthorized accounts was employees were pressured to meet unachievable sales goals. Wells has also pledged to end the controversial sales goal program for employees in the retail banking division. The financial meltdown of 2008 ... resulted out of extreme complexity - most politicians and citizens can’t parse a credit default swap. Opening a bank account in someone else’s name without their permission, however, is a wrong that everyone can understand.

Note: For more along these lines, see concise summaries of deeply revealing banking corruption news articles from reliable major media sources.

People who work at the U.S. Food and Drug Administration (FDA) as medical reviewers are responsible for parsing the risks and benefits of a particular drug before it gets the agency's approval. But a new report from two researchers at the Oregon Health and Science University, published in the journal The BMJ, suggests many of these medical reviewers go on to work for the drug companies they oversaw while working for the government. The study's authors ... looked at the FDA's list of haematology-oncology drug approvals from 2006 to 2010 and scanned all medical reviews from 2001 to 2010 in the agency's database, then looked up the subsequent jobs of the people who worked as medical reviewers for those drug approvals. The researchers found that among 55 people who worked as haematology-oncology medical reviewers from 2001 to 2010, 27 continued in their roles at the FDA, two people worked at the FDA but held other appointments, and 15 left the FDA to work with or consult for the biopharmaceutical industry. "If you know in the back of your mind that a major career opportunity after the FDA is going to work on the other side of the table, I worry it can make you less likely to put your foot down," says study author Dr. Vinay Prasad. "Regulators may be less willing to be very tough, and I worry that is happening." Prasad says he would like to see more transparency from the FDA on the number of people who go from the agency to the drug industry.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma from reliable major media sources.

Americans are taking more medications than ever before. Nearly 60 to 70 percent of us take at least one prescribed drug. Meanwhile, new drug approvals have reached a 19-year high. There's no formal process for quantifying injuries, hospitalizations or even deaths caused by therapeutic drug use – which excludes overdose or misuse. "Risk management begins with measuring things accurately, so you know what the threats are and the ones where you should be paying attention," says Thomas J. Moore ... at the Institute for Safe Medication Practices. But he notes that there's no system in place or accepted methodology for developing these tallies for prescription drugs, unlike with overdoses. Health providers and consumers are encouraged to report adverse drug reactions to the Food and Drug Administration. But the FDA says it's unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use. A ... recent analysis estimates 128,000 Americans die each year as a result of taking medications as prescribed. "By far the greatest number of [prescription drug-related] hospitalizations and deaths occur from drugs that are prescribed properly by physicians and taken as directed," says Donald Light ... lead author of a 2013 paper that detailed the estimate, entitled "Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs." "About 2,460 people per week are estimated to die from drugs that were properly prescribed," says Light.

Note: According to some studies, medical errors including adverse drug reactions may be the third leading cause of death in the US. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Unpublished field trials by pesticide manufacturers show their products cause serious harm to honeybees at high levels, leading to calls from senior scientists for the companies to end the secrecy which cloaks much of their research. The research, conducted by Syngenta and Bayer on their neonicotinoid insecticides, were submitted to the US Environmental Protection Agency and obtained by Greenpeace after a freedom of information request. Neonicotinoids are the world’s most widely used insecticides and there is clear scientific evidence that they harm bees at the levels found in fields. Neonicotinoids were banned from use on flowering crops in the EU in 2013, despite UK opposition. The newly revealed studies show Syngenta’s thiamethoxam and Bayer’s clothianidin seriously harmed colonies at high doses, but did not find significant effects below concentrations of 50 parts per billion (ppb) and 40ppb respectively. Such levels can sometimes be found in fields. However, scientists said all such research should be made public. “It is hard to see why the companies don’t make these kinds of studies available,” said Prof Dave Goulson, at the University of Sussex. “It does seem a little shady to do ... the very studies the companies say are the most important ones - and then not tell people what they find.” Syngenta had told Greenpeace in August that “none of the studies Syngenta has undertaken or commissioned for use by regulatory agencies have shown damages to the health of bee colonies”. Goulson said: “That clearly contradicts their own study.”

Note: CNN News reported in 2010 that Bayer covered up the link between its products and massive bee die-offs. Read more about how these pesticides sicken bees and harm food crops. For more along these lines, see concise summaries of deeply revealing food system corruption news articles from reliable major media sources.

In the 2000 biographical film about a legal clerk who brings a major utility company to its knees for poisoning residents of Hinkley, California, Erin Brockovich ended on a Hollywood high note with a $333m settlement from PG&E. But chromium-6 contamination of America’s drinking water is an ongoing battle the US Environmental Protection Agency (EPA) is losing. Nearly 200 million Americans across all 50 states are exposed to unsafe levels of chromium-6 or hexavalent chromium, a heavy metal known to cause cancer in animals and humans, according to a new report released Tuesday by the nonprofit research and advocacy organization Environmental Working Group (EWG). In their analysis of the EPA’s own data collected for the first nationwide test of chromium-6 contamination in US drinking water, the [EWG] found that 12,000 Americans are at risk of getting cancer. “More than two-thirds of Americans’ drinking water supply has more chromium than the level that California scientists say is safe – a number that’s been confirmed by scientists in both New Jersey and North Carolina,” according to [report co-author Bill] Walker. “Despite this widespread contamination, the US currently has no national drinking water standard for chromium-6.” Erin Brockovich urges Americans to disregard the EPA’s reassurances and to take a more active role in their communities to fix the country’s broken water supply.

Note: US authorities were recently caught systematically distorting water tests to downplay the pollution levels in the US water supply. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.